Hanmi Pharm. financials at a glance
| Year | Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
₩674.76B | ₩606.19B | ₩674.01B | ₩730.13B | ₩761.28B | ₩1.32T | ₩882.72B | ₩916.59B | ₩1.02T | ₩1.11T | ₩1.08T | ₩1.20T | ₩1.33T | ₩1.49T | ₩0.00M |
| GM % | Gross Margin % |
|
56.79% | 55.10% | 58.51% | 56.99% | 55.45% | 69.74% | 52.21% | 56.56% | 53.24% | 56.79% | 54.00% | 52.59% | 53.96% | 55.62% | 0.00% |
| OM | Operating Margin |
|
-1.13% | 3.50% | 7.14% | 8.48% | 4.53% | 16.08% | 3.03% | 8.96% | 8.23% | 9.33% | 4.55% | 10.42% | 11.56% | 15.08% | 0.00% |
| EPS | Earnings Per Share |
|
₩-473.79 | ₩118.51 | ₩4.04k | ₩2.94k | ₩12.07k | ₩1.95k | ₩4.87k | ₩1.99k | ₩4.17k | ₩939.50 | ₩5.27k | ₩7.99k | ₩11.52k | ₩0.00 | |
| Div. | Dividends |
|
₩410.14 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩1.74k | ₩443.99 | ₩452.87 | ₩461.92 | ₩471.16 | ₩480.58 | ₩490.20 | ₩488.81 | ₩0.00 |
| PR % | Payout Ratio % |
|
-86.57% | 0.00% | 0 | 0.00% | 0.00% | 0.00% | 89.21% | 9.12% | 22.72% | 11.08% | 50.15% | 9.12% | 6.13% | 4.24% | 0 |
| Sha. | Shares |
|
10.07m | 10.58m | 10.56m | 10.56m | 11.83m | 11.83m | 11.81m | 11.79m | 11.78m | 11.77m | 11.76m | 11.98m | 12.21m | 0m | 12.69m |
| OCF | Operating Cash Flow |
|
₩37.89B | ₩61.30B | ₩63.27B | ₩85.99B | ₩-32819.71M | ₩101.71B | ₩412.97B | ₩-62905.20M | ₩25.98B | ₩12.45B | ₩151.53B | ₩201.92B | ₩162.27B | ₩216.54B | ₩0.00M |
| FCF | Free Cash Flow |
|
₩-497.01M | ₩41.75B | ₩49.40B | ₩59.42B | ₩-101998.70M | ₩-19352.73M | ₩212.71B | ₩-309959.08M | ₩-156285.75M | ₩-153684.70M | ₩109.72B | ₩181.97B | ₩131.89B | ₩181.77B | ₩0.00M |
| FCFS | Free Cash Flow Per Share |
|
₩-1223.85 | ₩3.08k | ₩4.30k | ₩4.89k | ₩-9608.64 | ₩-3024.52 | ₩17.49k | ₩-28900.64 | ₩-15706.98 | ₩-14060.18 | ₩7.66k | ₩13.72k | ₩8.96k | ₩13.63k | ₩0.00 |